caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1366441362

Brian Henjum

Family PracticeMinnetonka, MNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Brian Henjum's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 8 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
RIDGEVIEW MEDICAL CENTER2161,554
David Gross
Diagnostic Radiology · Eden Prairie, MN
1223
LAFOND, NICHOLAS1147
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
RIDGEVIEW MEDICAL CENTER129847
Eric Nagle
Internal Medicine · Spring Park, MN
37284
Guy Runkle
Family Practice · St Paul, MN
18129
RAILE, GEOFFREY1542
LAFOND, NICHOLAS1548
David Gross
Diagnostic Radiology · Eden Prairie, MN
1335
SEATS, SHEILA1272
Christopher Meyer
Orthopedic Surgery · Waconia, MN
1125
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
36
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
3
Brand share
33.3%
Top prescribed drugs
Atorvastatin Calcium12 claims
Clopidogrel Bisulfate12 claims
Lisinopril12 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.